AbCellera Biologics Inc.（ABCL）價格預測ABCLAbCellera Biologics Inc.

Alphio's ABCL stock price prediction model matches the current AbCellera Biologics Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $12.26 (-0.86%). The 1-week path is $12.56 (+1.55%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Abcellera Biologics Inc is a good buy right now, trading at $12.545 with a forward P/E of 27.55, indicating potential for future earnings growth. The stock has recently seen a significant price target increase from analysts, with JPMorgan setting a target of $17, which represents a 35% upside from the current price. The stock's recent performance includes a year-to-date change of +265.74%, reflecting strong investor interest and momentum. However, the main risk is its negative net income margin of -1368.57%, which indicates ongoing financial challenges that investors should monitor closely.

AbCellera Biologics Inc. (ABCL) last closed at $12.37, losing -1.90%. These facts feed the 1-day and 1-week ABCL price prediction above.